This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Investing in your 20s can set the foundation for a secure retirement. Discover the best options to maximize your growth.
17,680 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Oil and currency markets tremble as new Iran-related tensions top the global agenda. Asia, with its export-led growth...
A patient investor could see a multi-year rebound in a little-known robotics stock. Learn the growth drivers, how to ...
Explore Viemed's 2026 earnings outlook with a practical, numbers-driven view. Learn the key drivers, risks, and how t...
As Zymeworks gears up for 2026 earnings, investors should focus on cash runway, pipeline milestones, and collaboratio...
Oil sits around $107.70 a barrel on May 11, 2026, supported by producer discipline and steady demand. The move could ...
Geopolitical shocks can destabilize oil markets. This guide explains why midstream oil stocks often prove resilient d...
CVS Health recently touched a fresh 52-week high after strong Q1 results. This deep dive explains why the rally may c...
Investors watching ecarx (ecx) 2026 earnings want clarity on how software, hardware, and services come together in th...
Daré (DARE) has a developing pipeline and a tight cash runway. This article breaks down what the Q4 2025 earnings cal...
Abercrombie & Fitch shares surged after a stronger-than-expected quarter. This article breaks down the factors behind...
Alaska Air Group stock surged this week as investors weighed fuel-cost pressures against resilient demand and discipl...